Your Patient Needs Jornay PM — Now What?

You've determined that Jornay PM is the right medication for your patient. The evening dosing aligns with their clinical needs, they've tried morning-dosed stimulants without adequate early-morning coverage, and you've written the prescription. But then your patient calls back: their pharmacy doesn't have it, the next pharmacy doesn't either, and they're running out of their current supply.

This is a familiar scenario for providers who prescribe Jornay PM. As the only evening-dosed ADHD stimulant on the market, it fills a critical clinical niche — but its brand-only status and limited pharmacy stocking create real access barriers for patients.

Here's a practical, step-by-step guide to helping your patients find and maintain access to Jornay PM.

Current Availability Landscape

As of 2026, Jornay PM supply from the manufacturer (Collegium Pharmaceutical) is stable. The medication is available through major wholesale distributors. The challenge is at the retail pharmacy level:

• Large chain pharmacies (CVS, Walgreens, Rite Aid) frequently do not stock Jornay PM due to low per-location demand
• Independent pharmacies are more likely to stock or order specialty medications
• Specialty/mail-order pharmacies that handle psychiatric medications often carry it routinely

The product is not in shortage — it's an availability and distribution challenge, not a supply problem.

Why Patients Can't Find It

Understanding the barriers helps you guide patients more effectively:

1. No generic exists. Only one manufacturer produces Jornay PM, limiting pharmacy options and increasing cost.
2. Insurance barriers reduce prescription volume. Prior authorization requirements and step therapy mandates mean fewer prescriptions overall, reducing pharmacy incentive to stock the product.
3. Retail pharmacy stocking thresholds. Most chains use automated inventory systems that only stock medications meeting minimum demand thresholds at each location.
4. CII prescribing complexity. Schedule II restrictions (no refills, new prescription each fill) mean patients must actively manage their supply chain monthly.

What Providers Can Do: 5 Practical Steps

Step 1: Direct Patients to Medfinder

Medfinder for Providers helps patients check real-time pharmacy availability for Jornay PM. Share this resource at the point of prescribing so patients can identify a stocking pharmacy before you send the prescription.

Step 2: E-Prescribe to Known Stocking Pharmacies

If your practice identifies pharmacies that reliably stock Jornay PM, build a reference list for your team. E-prescribe directly to those pharmacies when possible, avoiding the cycle of rejected fills and pharmacy transfers.

Step 3: Recommend Independent and Specialty Pharmacies

Coach patients to try independent pharmacies first. These pharmacies:

• Have more flexible ordering capabilities
• Often maintain relationships with specialty distributors
• Can typically order Jornay PM and have it in 1-2 business days
• Are more willing to add a medication to their standing inventory for a regular patient

Step 4: Proactively Address Insurance Barriers

Front-load the prior authorization process when prescribing Jornay PM:

• Submit prior authorization documentation with the initial prescription
• Document morning symptom burden and previous treatment failures
• Utilize Collegium's PA support resources at collegiumcoverage.com/jornay-pm
• Prepare appeal letters in advance for anticipated denials

Step 5: Set Up a Refill Workflow

Because Jornay PM is a CII medication requiring a new prescription each fill, consider implementing a proactive refill workflow:

• Schedule follow-up appointments to coincide with refill timing
• Use your EHR to set reminders for monthly prescription generation
• Provide patients with multiple post-dated prescriptions where state law permits
• Encourage patients to initiate the refill process 5-7 days before their supply runs out

When to Consider Alternatives

If a patient consistently cannot access Jornay PM despite these strategies, discuss alternatives:

• Concerta (methylphenidate ER): Same active ingredient, widely available as generic, morning dosing
• Vyvanse (lisdexamfetamine): Long-acting stimulant, now available as generic, up to 14 hours of coverage
• Adderall XR: Widely available generic, extended-release, morning dosing
• Non-stimulants: Qelbree (viloxazine) or Strattera (atomoxetine) for patients who need dosing flexibility

For a patient-facing comparison, direct them to: Alternatives to Jornay PM.

Workflow Tips for Your Practice

• Create a pharmacy reference card listing local pharmacies known to stock or order Jornay PM
• Add Medfinder to patient handouts — include the URL (medfinder.com) on after-visit summaries
• Brief front desk and MA staff on Jornay PM availability challenges so they can help patients troubleshoot
• Keep manufacturer resources accessible — bookmark collegiumcoverage.com for PA forms and jornaypm.com/savings for patient savings enrollment
• Document everything — pharmacy availability challenges and access barriers in the chart can strengthen future PA appeals

Final Thoughts

Jornay PM addresses a genuine clinical need that no other stimulant can replicate. The availability challenges are real but manageable with the right systems in place. By proactively directing patients to resources like Medfinder for Providers, building pharmacy relationships, and streamlining the PA process, your practice can help patients maintain consistent access to this important medication.

For the clinical perspective on Jornay PM supply status, see our provider briefing on the Jornay PM shortage. For cost-saving resources to share with patients, see our guide on helping patients save money on Jornay PM.